tiprankstipranks
Advertisement
Advertisement

GB:NFX Stock Latest News

Nuformix updates market on enlarged share capital and voting rights
Company AnnouncementsNuformix updates market on enlarged share capital and voting rights
13d ago
Nuformix Raises £1m to Accelerate NXP002 Fibrosis Programme
PremiumCompany Announcements
Nuformix Raises £1m to Accelerate NXP002 Fibrosis Programme
1M ago
Nuformix Wins US Orphan Drug Status for IPF Candidate NXP002
PremiumCompany Announcements
Nuformix Wins US Orphan Drug Status for IPF Candidate NXP002
1M ago
Nuformix Wins Strong Shareholder Backing as All AGM Resolutions Pass
PremiumCompany Announcements
Nuformix Wins Strong Shareholder Backing as All AGM Resolutions Pass
1M ago
Nuformix Posts 2025 Annual Report and Sets Date for 2026 AGM
PremiumCompany Announcements
Nuformix Posts 2025 Annual Report and Sets Date for 2026 AGM
2M ago
Nuformix Sharpens Focus on Partnering Lead IPF Drug NXP002 as Preclinical Data Strengthen Case
PremiumCompany AnnouncementsNuformix Sharpens Focus on Partnering Lead IPF Drug NXP002 as Preclinical Data Strengthen Case
3M ago
Nuformix PLC Updates Total Voting Rights Following New Share Issuance
Premium
Company Announcements
Nuformix PLC Updates Total Voting Rights Following New Share Issuance
5M ago
Nuformix Awaits FDA Response on Orphan Drug Designation for IPF Treatment
Premium
Company Announcements
Nuformix Awaits FDA Response on Orphan Drug Designation for IPF Treatment
5M ago
Nuformix plc Successfully Completes Oversubscribed Open Offer
PremiumCompany Announcements
Nuformix plc Successfully Completes Oversubscribed Open Offer
5M ago
Nuformix Launches £228,081 Open Offer to Advance Drug Repurposing Initiatives
PremiumCompany Announcements
Nuformix Launches £228,081 Open Offer to Advance Drug Repurposing Initiatives
6M ago
Nuformix Appoints New Auditor Amid Strategic Developments
PremiumCompany Announcements
Nuformix Appoints New Auditor Amid Strategic Developments
6M ago
Nuformix to Present NXP002 Insights at European Respiratory Congress
PremiumCompany Announcements
Nuformix to Present NXP002 Insights at European Respiratory Congress
7M ago
Nuformix Seeks US FDA Orphan Drug Designation for NXP002 in IPF
PremiumCompany AnnouncementsNuformix Seeks US FDA Orphan Drug Designation for NXP002 in IPF
8M ago
Nuformix Confirms Total Voting Rights Following Share Issuance
Premium
Company Announcements
Nuformix Confirms Total Voting Rights Following Share Issuance
11M ago
Nuformix Secures European Orphan Drug Designation for NXP002 in IPF
Premium
Company Announcements
Nuformix Secures European Orphan Drug Designation for NXP002 in IPF
11M ago
Nuformix plc Announces Prospectus for New Share Issuance
PremiumCompany Announcements
Nuformix plc Announces Prospectus for New Share Issuance
11M ago
Nuformix Announces £210,000 Placing to Advance Fibrosis Treatment Program
PremiumCompany Announcements
Nuformix Announces £210,000 Placing to Advance Fibrosis Treatment Program
11M ago
Nuformix Showcases Promising NXP002 Data at ATS Congress 2025
PremiumCompany Announcements
Nuformix Showcases Promising NXP002 Data at ATS Congress 2025
11M ago
Nuformix Reports Progress on NXP002 and Financial Results for H1 2025
PremiumCompany Announcements
Nuformix Reports Progress on NXP002 and Financial Results for H1 2025
12M ago
Nuformix’s NXP002 Receives Positive EMA Opinion for Orphan Drug Designation
PremiumCompany AnnouncementsNuformix’s NXP002 Receives Positive EMA Opinion for Orphan Drug Designation
12M ago
Nuformix’s NXP002 Programme Receives Positive EMA Opinion for Orphan Drug Designation
Premium
Company Announcements
Nuformix’s NXP002 Programme Receives Positive EMA Opinion for Orphan Drug Designation
12M ago
Nuformix Announces Office Relocation and New Company Secretary Appointment
Premium
Company Announcements
Nuformix Announces Office Relocation and New Company Secretary Appointment
12M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >